Semaglutide Weight Loss

Semaglutide (GLP-1) Weight Loss Programs

Semaglutide Wegovy and Ozempic are both medications originally used to treat type 2 diabetes. Each belongs to a class called GLP-1 receptor agonists that work for weight loss and treating diabetes by increasing the amount of insulin produced by the pancreas and decreasing the amount of glucose produced by the liver.

  • Semaglutide: Semaglutide is the key, active ingredient in Ozempic® and Wegovy®.

  • B12 Lipotropic Injections: Skinny Shot® lipo injections.

find perfect weight loss program

Amazing Weight Loss Journeys

Semaglutide for Weight Loss

Originally developed to help people with type 2 diabetes manage their blood sugar, semaglutide has emerged as a promising new tool for weight loss. This injectable medication, under the brand name Wegovy, specifically comes in a 2.4mg dose designed for once-weekly use in weight management. This reformulated version of semaglutide has garnered significant attention and approval due to its potential to support significant weight loss, with studies showing an average drop of 15% of body weight compared to those not taking the medication.

It’s important to remember that semaglutide is meant to be used alongside healthy lifestyle changes like diet and exercise for optimal weight management results. If you’re considering semaglutide, it’s crucial to consult with your doctor to discuss if it’s right for you and create a personalized weight management plan.

  • Mechanism of Action: Semaglutide belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists. It works by mimicking the effects of GLP-1, a naturally occurring hormone that increases insulin secretion, decreases glucagon production, and promotes feelings of fullness.

  • Clinical Trials: Multiple clinical trials exploring semaglutide for weight loss have shown promising results, with individuals with overweight or obesity losing significantly more weight when taking the injectable medication compared to those receiving a placebo. This suggests semaglutide has the potential to be a powerful tool for weight management.

  • Dosage and Administration: The recommended dosage for weight loss is 2.4 mg injected subcutaneously once a week. The injection is typically self-administered.

About Semaglutide (Wegovy®, Ozempic®)

Semaglutide Wegovy and Ozempic are both medications originally used to treat type 2 diabetes. Each belongs to a class called GLP-1 receptor agonists that work for weight loss and treating diabetes by increasing the amount of insulin produced by the pancreas and decreasing the amount of glucose produced by the liver. Semaglutide Wegovy is an injectable medication taken once per week, while Ozempic is an injectable medication that can be taken once/week or once daily. Both meds can be used in combination with other diabetes medications, such as metformin, to help control blood sugar levels. Both Semaglutide Wegovy and Ozempic have been shown to be effective in reducing HbA1c (a measure of blood sugar control over time), as well as body weight. They have been shown to reduce the risk of cardiovascular events, as well, in people with type 2 diabetes.

What’s the Difference?

One of the main differences between the two medications is their dosing schedule. Semaglutide Wegovy is taken once a week, while Ozempic can be taken once a week or once a day. This may make Ozempic a better option for people who prefer a daily dosing schedule or have trouble remembering to take their medication once a week. Another difference between the two medications is their potential side effects. The most common side effects of Semaglutide Wegovy and Ozempic include nausea, diarrhea, and constipation. Some people may also experience mild to moderate hypoglycemia (low blood sugar) when taking these medications, so it’s important to monitor your blood sugar levels closely.

Find Your Perfect Program
Encuentra tu programa perfecto

Complete the Form Below to Discover Which Program Works Best For You?